Lifestyle Intervention for Obesity
Trial Summary
Do I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are currently using weight loss medication, you cannot participate in the trial.
What data supports the idea that Lifestyle Intervention for Obesity is an effective treatment?
The available research shows that Lifestyle Intervention for Obesity can lead to significant weight loss. For example, one study found that people who completed the program lost an average of 8-10% of their initial body weight in about 30 weeks. Another study reported an average weight loss of 10 kg by the end of a short-term program, with some weight still lost after a year. These results suggest that the treatment is effective in helping people lose weight. Additionally, lifestyle interventions have been shown to improve quality of life and reduce health risks associated with obesity. Compared to other methods, such as Internet-based programs, on-site lifestyle interventions tend to result in greater weight loss. Overall, these findings indicate that lifestyle interventions are a promising approach for managing obesity.12345
What safety data exists for the lifestyle intervention for obesity?
The provided research abstracts do not specifically mention safety data for the lifestyle intervention for obesity. They focus on the effectiveness, challenges, and implementation of lifestyle interventions for weight loss and obesity management. To find specific safety data, further detailed studies or clinical trial reports would be needed.15678
Is the 12-week lifestyle intervention a promising treatment for obesity?
Yes, the 12-week lifestyle intervention is promising for treating obesity. It helps people adopt healthier habits, like better eating and more exercise, which can lead to weight loss and improved health. Studies show that lifestyle changes can be effective in managing obesity and can be adapted to fit different people's needs.158910
What is the purpose of this trial?
African American adults that live in economically disadvantaged areas are at an increased risk for obesity and cardiometabolic disease. The treatment program being tested in this research study aims to address these factors and increase outcomes for the study population. The purpose of this research study is to find out about the feasibility and acceptability of using house chats (HC) as a model for a weight loss program in a real-world, community-based setting.
Research Team
Moghboeba Mosavel
Principal Investigator
Virginia Commonwealth University
Eligibility Criteria
This trial is for African American adults who are at least 18 years old and live in Petersburg, VA. It's designed to help those living in economically disadvantaged areas reduce obesity and improve heart health through a community-based program.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week lifestyle intervention delivered via weekly group meetings in the HCL's homes
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12 and 24 weeks post-treatment
Long-term follow-up
Mixed methods approach to assess factors that might promote and/or interfere with sustainability over long-term follow-up
Treatment Details
Interventions
- 12-week lifestyle intervention
12-week lifestyle intervention is already approved in United States for the following indications:
- Weight loss
- Obesity prevention
- Cardiometabolic disease prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator